Quten Research Institute, Limited Liability Company
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Quten Research Institute, Limited Liability Company - overview
Established
2007
Location
-, NJ, US
Primary Industry
Food
About
Based in New Jersey, US, and founded in 2007, Quten Research Institute, LLC provides a variety of supplements such as CoQ10 supplements, etc. In July 2023, Sanofi S. A. , a portfolio company of Advanz Pharma Services (UK) Limited and Nordic Capital, agreed to acquire Quten Research Institute, a Limited Liability Company.
The transaction is expected to be completed in Q3 2023. The business sells Qunol, which offers a range of nutritional supplements, from the high-absorption form of turmeric curcumin to the version of CoQ10 that is recommended by cardiologists. The firm supplement range includes turmeric, magnesium, omega-3, sleep, and many more in liquid, tablet, and gummies form. The firm generates its revenue by charging for its supplement product range.
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements
Website
www.qunol.com
Verticals
E-commerce, Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.